Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1KBYX | ISIN: US98978V1035 | Ticker-Symbol: ZOE
Tradegate
13.11.24
21:57 Uhr
166,78 Euro
-0,90
-0,54 %
Branche
Pharma
Aktienmarkt
S&P 500
1-Jahres-Chart
ZOETIS INC Chart 1 Jahr
5-Tage-Chart
ZOETIS INC 5-Tage-Chart
RealtimeGeldBriefZeit
166,62169,5613.11.
166,40168,9813.11.
ACCESSWIRE
209 Leser
Artikel bewerten:
(1)

The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis

Finanznachrichten News

The partnership joins forces to support arthritis patients and their beloved pets

ATLANTA, GA / ACCESSWIRE / November 12, 2024 / The Arthritis Foundation welcomes Zoetis, maker of innovative therapies for osteoarthritis pain in pets, as the two-year National Presenting Sponsor of the Jingle Bell Run and Walk to Cure Arthritis. Zoetis' commitment to supporting arthritis patients, whether they have two legs or four, is invaluable as the Arthritis Foundation works to raise awareness of its tools and resources for people living with the serious impacts of arthritis-the leading cause of disability in the US.

"Zoetis' support as Presenting Sponsor of Jingle Bell Run through 2025 and Walk to Cure Arthritis through 2026 will help us fund the next generation of treatment research and provide life-changing science, resources, advocacy and community connections to people living with arthritis," said Steven Taylor, President and CEO of the Arthritis Foundation. "Studies show that spending time with a beloved dog, cat or other pet has real physical and mental health benefits for people with arthritis. By advancing care for animals, Zoetis stands by people with arthritis and their pets."

As part of this partnership, Zoetis will activate at select Jingle Bell Run events in 2024 and 2025 and Walk to Cure Arthritis events in 2025 and 2026, providing educational resources and tools to pet owners on how to recognize the signs and symptoms of osteoarthritis pain in their dogs and cats. This December, Zoetis will be present at dog-friendly Jingle Bell Runs in Arizona, Arkansas, California, Colorado, Florida, Georgia, Kansas, Kentucky, New Jersey, New York, Ohio, Pennsylvania, Oklahoma, Texas, Washington State and Washington D.C. Zoetis will be offering pets and pet owners an arthritis friendly leash (while supplies last), treats, water and pet care information at their exhibit booth during these events.

"Sadly, nearly 40% of dogs and cats,[1][2] respectively, will suffer from osteoarthritis in their lifetime. Everyday activities can be painful for them and even worse, we may miss the subtle signs of this pain, which may indicate an early onset of the disease and negatively impact their wellbeing, as well as the special bond we share with them. That's why maintaining a strong relationship with your veterinarian is such an important part of controlling your pet's OA pain," said Ester Banque, Executive Vice President and President, U.S. Operations, Zoetis. "We are eager to partner with Arthritis Foundation due to our shared dedication to advancing care and improving quality of life for those living with arthritis - whether those in need have two legs or four. We look forward to engaging with the many pet lovers in the arthritis community."

Arthritis Foundation events aim to help people with arthritis better manage their disease and connect with others in the arthritis community. Jingle Bell Run and Walk to Cure Arthritis participants, donors and fundraisers not only show support for loved ones with arthritis, but also fuel the Foundation's scientific research, educational resources and opportunities to connect.

For more information, visit arthritis.org. ?

About the Arthritis Foundation

The Arthritis Foundation is fighting for all people who live with arthritis. As Champions of Yes, the Arthritis Foundation has a mission to turn the obstacles arthritis causes into opportunities. The Arthritis Foundation not only champions life-changing solutions and medical advancements, but it also provides ways for people to connect, break down barriers in health care, and join the fight to conquer arthritis - uniting hearts, minds, and resources to change the future of arthritis.

About Zoetis

As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide - from veterinarians and pet owners to livestock farmers and ranchers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetispetcare.com.

CONTACT:

Julie Thomas
jthomas@mower.com
212.980.9064

[1] IHS Markit. (2021) Canine and Feline Pain Market 2021: Animal Health Market Analysis; Wright A, et al. Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests. J Small Anim Pract, 2022. http://doi.org/10.1111/jsap.13500.
[2] Enomoto, M, et al., Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Rec, 2019.

SOURCE: The Arthritis Foundation



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.